Actavis Seeking FDA Approval to Market Generic Version of Gilead Drug

Actavis PLC said Friday that it is seeking approval from the U.S. Food and Drug Administration to sell a generic version of Gilead Sciences Inc.’s pulmonary arterial hypertension treatment.



from WSJ.com: US Business http://ift.tt/1Ck2ybw

via IFTTT